Physician profile
Chuansheng Wu
NPI 1275578361
$17,309.64
in general payments reported to CMS, 2019-2025
54 companies · $3,234 in 2025
The $3,234 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,865 · 2020: $2,490 · 2021: $1,527 · 2022: $1,767 · 2023: $3,478 · 2024: $2,949 · 2025: $3,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,239 · Consulting Fee: $2,193 · Education: $211 · Travel and Lodging: $17.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,239.37 |
| Consulting Fee | $2,193.00 |
| Education | $210.79 |
| Travel and Lodging | $17.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $3,053.33 | 2019-2025 | |
| Glaxosmithkline, LLC. | $2,012.94 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals Lp | $1,623.45 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,245.35 | 2019-2025 | Ofev, Jascayd |
| Actelion Pharmaceuticals US, INC. | $978.29 | 2019-2025 | Opsumit, Uptravi |
| Fisher & Paykel Healthcare Limited | $700.00 | 2025 | Fisher & Paykel Healthcare |
| Merck Sharp & Dohme LLC | $697.56 | 2019-2025 | Winrevair, Belsomra |
| Regeneron Healthcare Solutions, INC. | $628.35 | 2019-2025 | Dupixent |
| Insmed, INC. | $624.77 | 2019-2024 | Arikayce |
| Sunovion Pharmaceuticals INC. | $558.19 | 2019-2021 | |
| Grifols USA, LLC | $496.36 | 2019-2025 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $493.77 | 2019-2024 | |
| Harmony Biosciences LLC | $435.96 | 2020-2025 | Wakix |
| Ani Pharmaceuticals, INC. | $400.89 | 2023-2025 | Purified Cortrophin Gel |
| Bayer Healthcare Pharmaceuticals INC. | $377.43 | 2019-2025 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chuansheng Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.